Adults with mild to severe obstructive sleep apnea achieved lower disease severity with AD109, an oral combination drug, at ...

Median disease-free survival (DFS) increased from 4.8 months with placebo to 9.9 months with adjuvant atezolizumab (Tecentriq ...

Testosterone is being hailed as the secret to better energy, mood, and sex drive. Here’s what experts say about when it ...

Experts say there are some components of the cannabis plant “that appear to be helpful for some people with regard to sleep." ...

Eli Lilly And Company (($LLY)) announced an update on their ongoing clinical study. Study Overview: Eli Lilly and Company is initiating a Phase 2 ...

When pembrolizumab was added to paclitaxel with or without bevacizumab in platinum-resistant ovarian cancer, significant ...

For too long in the Western world, ageing has been perceived as something negative, especially for women. The message we ...

Topline data were announced from two phase 3 trials evaluating ulixacaltamide in patients with essential tremor.

Talk about bad blood. Health experts are sounding the alarm over a disturbing trend where drug users swap blood to score a ...

Atezolizumab improved DFS and OS in ctDNA-positive MIBC patients, with a median DFS of 9.9 months vs 4.8 months for placebo. Serial ctDNA testing may offer a more accurate assessment of MRD and early ...

Figs may have benefits for gut and menstrual health and reduce inflammation that causes disease. They are rich in ...

Vitamin D2 supplements may negatively impact circulating levels of vitamin D3 and negate the latter's potential benefits, ...